Proangiogenic effects of ionizing irradiation on squamous cell carcinoma of the hypopharynx

Auris Nasus Larynx

Volumn 35, Issue 3, 2008, Pages 369-375

  Koutsimpelas, D ^a   Brieger, J ^a   Kim, D W ^a   Stenzel, M ^a   Hast, J ^a   Mann, W J ^a  

^a UNIVERSITY MEDICAL CENTER MAINZ   (Germany)

Author keywords

CD31; flk 1; flt 1; Irradiation; Ki 67; SCC; VEGF

Indexed keywords

VASCULOTROPIN; VASCULOTROPIN RECEPTOR 1; VASCULOTROPIN RECEPTOR 2;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER CELL CULTURE; CELL PROLIFERATION; CONTROLLED STUDY; HEAD AND NECK CARCINOMA; HUMAN; HUMAN CELL; HYPOPHARYNX CARCINOMA; IMMUNOHISTOCHEMISTRY; IONIZING RADIATION; MICROVASCULATURE; MOUSE; NONHUMAN; PROTEIN EXPRESSION; TUMOR GROWTH; XENOGRAFT;

ANIMALS; CARCINOMA, SQUAMOUS CELL; CELL DIVISION; HUMANS; KI-67 ANTIGEN; MICE; MICE, NUDE; MICROCIRCULATION; NEOPLASM TRANSPLANTATION; NEOVASCULARIZATION, PATHOLOGIC; OTORHINOLARYNGOLOGIC NEOPLASMS; RADIOTHERAPY DOSAGE; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-1; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-2;

EID: 47549087747     PISSN: 03858146     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.anl.2007.09.004     Document Type: Article

References (35)

1. Weichselbaum R.R., Dahlberg W., Beckett M., Karrison T., Miller D., Clark J., et al. Radiation-resistant and repair-proficient human tumour cells may be associated with radiotherapy failure in head- and neck-cancer patients. Proc Natl Acad Sci USA 83 (1986) 2684-2688
2. Lichter A.S., and Lawrence T.S. Recent advances in radiation oncology. New Engl J Med 332 6 (1995) 371-379
3. Paris F., Fuks Z., Kang A., Capodieci P., Juan G., Ehleiter D., et al. Endothelial apoptosis as the primary lesion initiating intestinal radiation damage in mice. Science 13 (2001) 293-297
4. Garcia-Barros M., Paris F., Cordon-Cardo C., Lyden D., Rafii S., Haimowitz-Friedman, et al. Tumor response to radiotherapy regulated by endothelial cell apoptosis. Science 302 5652 (2003) 1155-1159
5. Gorski D.H., Beckett M.A., and Jaskowiak NT. Blockade of the vascular endothelial growth factor stress response increases the anti tumour effect of ionizing radiation. Cancer Res 59 14 (1999) 3374-3378
6. Ferrara N., Houk K., Jakemann L., and Leung D.W. Molecular and biological properties of the vascular endothelial growth factor family of proteins. Endocr Rev 13 1 (1992) 18-32
7. Gupta V.K., Jaskowiak N.T., Beckett M.A., Mauceri H.J., Grunstein J., Johnson R.S., et al. Vascular endothelial factor enhances endothelial cell survival and tumour radioresistance. Cancer J 8 1 (2002) 47-54
8. Kermani P., Leclerc G., Martel R., and Fareh J. Effect of ionizing radiation on thymidine uptake, differentiation and VEGFR2 receptor expression in endothelial cells: the role of VEGF (165). Int J Radiat Oncol Biol Phys 50 1 (2001) 213-220
9. Welkoborsky H.J., Jacob R., Riazimand S.H., Bernauer H., and Mann W.J. Molecular biologic characteristics of seven new cell lines of squamous cell carcinomas of the head and neck and comparison to fresh tumour tissue. Oncology 65 1 (2003) 60-71
10. Vlachtsis K., Brieger J., Kim D.W., Gieringer R., Hast J., Hengstler J.G., et al. Quantitative analysis of VEGF-isoforms in head and neck squamous cell carcinoma cell lines: relation to xenotransplantability and tumour progression in mice. Oncol Rep 9 5 (2002) 1133-1138
11. Weidner N., Semple J.P., Welch W.R., and Folkman J. Tumor angiogenesis and metastasis-correlation in invasive breast carcinoma. N Engl J Med 324 1 (1991) 1-8
12. Weidner N. Current pathologic methods for measuring intratumoral microvessel density within breast carcinoma and other solid tumors. Breast Cancer Res Treat 36 2 (1995) 169-180
13. Gosepath J., Brieger J., Lehr H.A., and Mann W.J. Expression, localization and significance of vascular permeability/vascular endotelial growth factor in nasal Polyps. Am J Rhinol 19 1 (2005) 7-13
14. Heinrich UR, Brieger J, Selivanova O, Feltens R, Eimermacher A, Schäfer D, et al.: COX-2 expression in the guinea pig cochlea is partly altered by moderate sound exposure. Neurosci Lett 2006; 13; 394(2):121-126.
15. Hast J., Schiffer I.B., Neugebauer B., Teichman E., Schreiber W., Brieger J., et al. Angiogenesis and fibroblast proliferation precede formation of recurrent tumours after radiation therapy in nude mice. Anticancer Res 22 2a (2002) 677-688
16. Adelstein D.J., Saxton J.P., Lavertu P., Wood B.G., Wanamaker J.R., Eliachar I., et al. A phase III randomised trial comparing concurent chemotherapy and radiotherapy with radiotherapy alone in resectable stage III and IV squamous cell head and neck cancer: preliminary results. Head Neck 19 7 (1997) 567-575
17. Barleon B., Siemeister G., Martiny-Baron G., Weindel K., Herzog C., and Marme D. Vascular endothelial growth factor up-regulates its receptor fms-like tyrosine kinase (FLT-1) and a soluble variant of FLT-1 in human vascular endothelial cells. Cancer Res 57 23 (1997) 5421-5425
18. Liu W., and Ellis L.M. Regulation of vascular endothelial growth factor receptor KDR in vitro by a soluble factor in confluent endothelial cells. Pathobiology 66 5 (1998) 247-252
19. Shen B.Q., Lee D.Y., and Gerber H.P. Homologus up-regulation of KDR/Flk-1 receptor expression by vascular endothelial growth factor in vitro. J Biol Chem 273 45 (1998) 29979-29985
20. Terman B.I., Dougher-Vermazen M., Carrion M.E., Dimitrov D., Amellino D.C., Gospodarowic D., et al. Identification of the KDR tyrosine kinase as a receptor for vascular endothelial growth factor. Biochem Biophys Res Commun 187 3 (1992) 1578-1586
21. Brieger J., Schroeder P., Gosepath J., and Mann W.J. Vascular endothelial growth factor and basic fibroblast growth factor are released by squamous cell carcinoma cell lines after irradiation and increase resistance to subsequent irradiation. Int J Mol Med 16 1 (2005) 159-164
22. Fukumura D., Xavier R., Sugiura T., Chen Y., Park E.C., Lu N., et al. Tumor induction of VEGF promoter activity in stromal cells. Cell 94 6 (1998) 715-725
23. Hlatky L., Tsionou C., Hahnfeldt P., and Coleman C.N. Mammary fibroblasts may influence breast tumour angiogenesis via hypoxia-induced vascular endothelial growth factor up-regulation and protein expression. Cancer Res 54 23 (1994) 6083-6086
24. Pilch H., Schlenger K., Steiner E., Brockerhoff P., Knapstein P., and Vaupel P. Hypoxia-stimulated expression of angiogenic growth factors in cervical cancer cells and cervical cancer-derived fibroblasts. Int J Gynecol Cancer 11 2 (2001) 137-142
25. Cross M.J., and Claesson-Welsh L. FGF and VEGF function in angiogenesis: signaling pathways, biological responses and therapeutic inhibition. Trends Pharmacol Sci 22 4 (2004) 201-207
26. Angelov L., Salhia A., Roncari L., McMahon G., and Guha A. Inhibition of angiogenesis by blocking activation of the vascular endothelial factor receptor 2 leads to decreased growth of neurogenic sarcomas. Cancer Res 59 21 (1999) 5536-5541
27. Borgström P., Bourdon M.A., Hillan K.J., Sreramareo P., and Ferrara N. Neutralizing anti-vascular endothelial growth factor antibody completely inhibits angiogenesis and growth of human prostate carcinoma tumors in vivo. Prostate 35 1 (1998) 1-10
28. Hess C., Vuong V., Hegyi I., Riesterer O., Wood J., Fabbro D., et al. Effect of VEGF receptor inhibitor PTK787/ZK222584 combined with ionizing radiation on endothelial cells and tumour growth. Br J Cancer 85 12 (2001) 2010-2016
29. Huang S.M., Li J., Armstrong E.A., and Harari P.M. Modulation of radiation response and tumour-induced angiogenesis after epidermal growth factor receptor I inhibition by ZD 1839 (Iressa). Cancer Res 62 15 (2002) 4300-4306
30. Kim K.J., Li B., Houck K., Winer J., and Ferrara N. The vascular endothelial growth factor proteins: identification of biologically relevant regions by neutralizing monoclonal antibodies. Growth Factors 7 1 (1992) 53-64
31. Lee C.G., Heiin M., di Tomaso E., Griffon-Etienne G., Ancukiewicz M., Koike C., et al. Anti-vascular endothelial growth factor treatment augments tumor radiation response under normoxic or hypoxic conditions. Cancer Res 60 19 (2000) 5565-5570
32. Mauceri H.J., Hanna N.N., and Beckett M.A. Combined effects of angiostatin and ionizing radiation in antitumor therapy. Nature 394 6690 (1998) 287-291
33. Ning S., Laird D., Cherrington J.M., and Knox S.J. The antiangiogenic agents SU5416 and [6668SU] increase the antitumor effects of fractioned irradiation. Radiat Res 157 1 (2002) 45-51
34. Prewett M., Huber J., Li Y., Santiago A., O'Connor W., King K., et al. Antivascular endothelial growth factor receptor (fetal liver kinase I) monoclonal antibody inhibits tumour angiogenesis and growth of several mouse and human tumours. Cancer Res 59 20 (1999) 5209-5218
35. Lin P., Sankar S., Shan S., Dewhirst M.W., Polverini P.J., Quinn T.Q., et al. Inhibition of tumour growth by targeting tumour endothelium using a soluble vascular endothelial growth factor receptor. Cell Growth Differ 9 12 (1998) 49-58